Shockwave Medical, Inc. SWAV recently announced that the researchers provided interim long-term follow-up results of up to three years, along with six-month data from the entire population of the ...
SANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...
Photo Credit: Adapted from Verheye S. The coronary sinus reducer. Presented at: TCT 2023. San Francisco, CA. An implantable coronary sinus reducer (CSR)—Shockwave Reducer (Shockwave Medical)—likely ...
A fully independent clinical trial researchers thought might disprove a cardiac device made by Shockwave Medical, the company that Johnson & Johnson is buying for $13 billion, ended up providing some ...
Good afternoon and welcome to Shockwave's Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session ...
Shockwave Medical Inc. will acquire Neovasc Inc. for just under $108 million, if all terms of the deal are met. Shockwave will pay $27.25 in cash for each of Neovasc’s 2.71 million outstanding shares ...
Santa Clara, California--(Newsfile Corp. - April 11, 2023) - Shockwave Medical, Inc. (NASDAQ: SWAV) ("Shockwave"), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results